1 / 9

HIV GENOTYPE ASSAY

HIV GENOTYPE ASSAY. Anabelia Perez, MLT (ASCP) Molecular Technologist August 6, 2008. CLINICAL REASON. The ViroSeq HIV-1 Genotype Assay is clinically used: Detect HIV genomic mutations that confer resistance to specific types of antiretroviral drugs

yates
Download Presentation

HIV GENOTYPE ASSAY

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. HIV GENOTYPE ASSAY Anabelia Perez, MLT (ASCP) Molecular Technologist August 6, 2008

  2. CLINICAL REASON The ViroSeq HIV-1 Genotype Assay is clinically used: • Detect HIV genomic mutations that confer resistance to specific types of antiretroviral drugs • To aid in monitoring and treating HIV infections.

  3. PRINICPLE The ViroSeq HIV-1 Genotyping System is based on six major processes: • Sample Preparation • Reverse Transcription (RT) • Polymerase Chain Reaction (PCR) • Cycle Sequencing • Automated Sequence Detection • Software Analysis

  4. SAMPLE PREPARATION • Isolate HIV-1 viral RNA from 0.5mL of EDTA human plasma • 1 hour centrifuge at 4°C • HIV virus particles in pellet are disrupted with Viral Lysis Buffer • Precipitation with Isopropanol • Purification with 70% Ethanol • RNA is dried and resuspended with Diluent

  5. REVERSE TRANSCRIPTION The ViroSeq HIV-1 Genotype Assay amplifies 1.8 Kb region of the HIV-1 pol gene that spans the entire protease gene and approximately two-thirds of the reverse transcriptase (RT) gene. Single-stranded complementary DNA is generated.

  6. POLYMERASE CHAIN REACTION PCR Reaction (40 cycles for PCR step) • 1st step: 93°C for 20 sec to denature DNA into single strands • 2nd step: 64°C for 45 sec to anneal primer • 3rd step: 66°C for 3 min to extend primer to create double-stranded DNA Amplicons are created and heated to 72° C for 10 min to allow final extension and then cooled down to 4°C infinity for next procedure

  7. CYCLE SEQUENCING Cycle Sequencing has 4 steps: • PCR purification- removes unincorporated dNTPs & primers • DNA quantitation- gel electrophoresis • Cycle sequencing- 7 primers (4 forward & 3 reverse) to sequence entire region Protease (codon 1-99) and two-thirds RT region (1-335). Big Dye Terminator chemistry is used to permit a resolution of 600 bases on the 3100 Genetic Analyzer • Sequence Purification-removes unincorporated Big terminators from samples so they do not interfere with sample sequencing & analysis. Method: Centri-Sep 96 column spin plates are used at CPL. (Cost effective). Purified cycle sequence reactions are resuspensed in Hi Hi formamide.

  8. AUTOMATED SEQUENCE DETECTION • 3100 Genetic Analyzer- ABI Prism automated sequencers detect fluorescence from different dye terminators that are used to identify the A C G T bases. Each dye emits light at a different wavelength when excited by an argon ion laser. All four bases are then detected & distinguished in a single capillary. • Sequencing involves creating an electrical flow of ions from negative to positive thru POP-6 medium which involves smaller-size fragments migrating faster than larger-size fragments thru field. • Each fragment passes by the laser read region & it is excited by the laser • Fluorescence is detected by a CCD camera & converted to a sequence basecall by the Sequence Analysis software • Resulting File contains the sequence information for each of the 7 primers in each sample

  9. SUMMARY & EXPLANATION The ViroSeq HIV-1 Genotyping System detects mutations in the RT and protease regions of the pol gene and provides the physician with a report indicating genetic evidence of viral resistance. It is a complete system that provides reagents for viral RNA isolation from plasma, RT-PCR, and sequencing. The entire protease gene and two-thirds of the Rt gene are amplified to generate a 1.8 kb amplicon. The amplicon is used as a sequencing template for seven primers that generate an approx. 1.3 kb consensus sequence. The software compares the consensus sequence with a reference, HXB-2, to determine mutations present In the sample. Finally, the ViroSeq software uses a proprietary algorithm to analyze the mutations and generate a drug resistance report.

More Related